Is Gabapentin legal in Saudi Arabia?

Legal status

Gabapentin is a controlled psychotropic substance in Saudi Arabia, placed at Schedule II Category E of the schedules attached to the Law of Combating Narcotics and Psychotropic Substances, Royal Decree M/39 of 1426 AH, in the version of those schedules issued on 4 September 2026. The schedule prints «جابابنتين» under the heading «فئة (هـ):... المؤثرات العقلية الخاضعة للرقابة محلياً بالمملكة», Category E, psychotropic substances locally controlled in the Kingdom. Category E is the Kingdom's own domestic list, and gabapentin is the clearest illustration of why that list matters: it is not in the international psychotropic conventions, so a traveller checking the treaty tables would find nothing and conclude it was an ordinary medicine. In Saudi Arabia it is controlled, and it is controlled by a decision the Kingdom took for itself. M/39 Articles 1 and 70 to 71 are cited for identification and for keeping the attached schedules current.

Consequences if caught

A Schedule II Category E placement is a placement in the schedules, so Article 37(I) is available, and it states no quantity at all. The penalty articles do not sort by category letter: the conduct named is smuggling, receipt from a smuggler, and import, export, manufacture, production, extraction or cultivation with intent to promote, together with the repeat promotion histories the article sets out, with no weight threshold anywhere in it. Death under Article 37(I) is a statutory ta'zir penalty and it is not mandatory, because Article 37(II) gives the court the power to reduce it; where the court does reduce, the substitute is a prison term of not less than fifteen years with the lashes and the fine the article states. No express life imprisonment wording was found anywhere in M/39. Articles 38 to 41 are cited as the tiers below Article 37, and an undeclared personal supply is a case about the missing permit rather than about trafficking. The conduct Article 37(I) names is smuggling, receipt from a smuggler and import, export or manufacture with intent to promote, which is not what a patient travelling with a gabapentin prescription is doing. For that person the operative requirement is the advance SFDA clearance, not the capital tier. The distinction is the article's own and the dossier supports nothing beyond it.

If prescribed or medical

The Saudi traveller rule is a permit rule rather than a prescription rule, and gabapentin is a medicine where travellers are most likely to be caught out by not knowing it is controlled at all. A controlled medicine may be brought in only under a clearance obtained from the SFDA before travel through its Controlled Drugs System, and that advance electronic clearance is required rather than optional. A prescription written abroad is not a Saudi clearance. Gabapentin sits inside that regime as a Schedule II Category E substance locally controlled in the Kingdom, so the clearance question governs it, whatever its status is at home.

Documentation

Apply through the SFDA Controlled Drugs System before travelling rather than on arrival, and carry the clearance itself and not the prescription alone. Bring the medicine in its original dispensing packaging with the prescription and a medical report naming the patient, the active ingredient, the dose and the treatment period, translated into Arabic and dated less than six months before travel, keep the quantity to a one month supply or the length of the stay, whichever is shorter, and declare it at customs; advance electronic clearance has been required since 1 November 2025. Do not rely on gabapentin being uncontrolled where the prescription was written. The permit mechanics stated here are the SFDA traveller rules recorded on the current live cell and were not re-derived from the instrument in this pass. The Schedule II Category E placement was read in the 4 September 2026 schedules on 17 September 2026.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Saudi Arabia’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.